result
outcomes research
A New Spark in
Cancer Therapy
A platinum-based nanodrug may outshine
traditional chemotherapy.
Read now
Popular Features
precision medicine
Advances in Glioblastoma Research
Houston Methodist researchers are testing drugs developed by Texas A&M University colleagues to treat glioblastomas—the most deadly and aggressive primary brain malignancy.
Read now
Amplifying the Invisible: Unlocking Genomes That Matter
Rodrigo de Paula Baptista, PhD, and his team are using multiple displacement amplification (MDA) with Nanopore sequencing to unlock high-quality genomes from tiny or degraded samples.
Read now
outcomes research
Focus
Innovative Education
Community Health Worker Program Expands Cancer Preventative Services Reach
As part of its long-standing partnership with Legacy Community Health, Houston Methodist is now home to C-CUR, a community health worker-led program that provides vulnerable populations assistance in cancer screening and care.
Read now
Clinical Research
Advancements in Renal Transplantation Methodology
Houston Methodist researchers publish a novel one-stage method to improve patient outcomes in renal transplantation patients with severe atherosclerosis.
Read now
Outcomes Research
Gut Microbiota as a Therapeutic Target
Houston Methodist researchers are modulating the gut microbiome dysbiosis to reduce neuroinflammation and find therapeutic solutions for neurodegenerative diseases.
Read now
Restorative Medicine
Progress for Parkinson’s
New research uncovers mechanistic insights into Parkinson’s disease.
Read now
Precision Medicine
Tiny Cell Messengers in Obese Individuals Accelerate Alzheimer’s-linked Plaque Buildup in the Brain
A first-of-its-kind study from Houston Methodist found that adipose-derived extracellular vesicles—tiny cell-to-cell messengers in the body—can signal the buildup plaques that are a key feature of Alzheimer’s disease.
Read now